DMK PHARMACEUTICALS Corp: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- $4.8M
- Net Income/Loss (FY2022)
- -$26.5M
- Total Assets (FY2022)
- $10.9M
- Total Equity (FY2022)
- -$808.1K
- Cash Flows from Operating Activities (FY2022)
- -$25.9M
Source: DMK PHARMACEUTICALS Corp 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
